Author:
Lewallen Susan,Courtright Paul
Reference11 articles.
1. Hogeweg M, Kiran KU, Suneetha S (1991) The significance of facial patches and type I reaction for the development of facial nerve damage in leprosy. A retrospective study among 1226 paucibacillary leprosy patients. Lepr Rev 62:143–149
2. Kiran KU, Hogeweg M, Suneetha S (1991) Treatment of recent facial nerve damage with lagophthalmos, using a semistandard steroid regimen. Lepr Rev 62:150–154
3. Courtright P, Hu LF, Li HY, Lewallen S (1994) Multidrug therapy and eye disease in leprosy: a cross-sectional study in the People’s Republic of China. Int J Epidemiol 23:835–842
4. Lewallen S, Tungpakorn NC, Kim SH, Courtright P (2000) Progression of eye disease in “cured” leprosy patients: implications for understanding the pathophysiology of ocular disease and for addressing eye care needs. Br J Ophthalmol 84:817–821
5. Ffytche TJ (1981) Role of iris changes as a cause of blindness in lepromatous leprosy. Br J Ophthalmol 65:231–239